HER2 amplification status in breast cancer: a comparison between immunohistochemical staining and fluorescence in situ hybridisation using manual and automated quantitative image analysis scoring techniques.
about
IHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samplesOestradiol induced inhibition of neuroendocrine marker expression in Leydig cells of adult ratsThe development and validation of the Virtual Tissue Matrix, a software application that facilitates the review of tissue microarrays on line.Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysis.Software-automated counting of Ki-67 proliferation index correlates with pathologic grade and disease progression of follicular lymphomas.Image analysis as an adjunct to manual HER-2 immunohistochemical review: a diagnostic tool to standardize interpretationIncreased mortality in HER2 positive, oestrogen receptor positive invasive breast cancer: a population-based studySerine protease PRSS23 is upregulated by estrogen receptor α and associated with proliferation of breast cancer cells.Evaluation of BrightGen HR RT-qDx assay to detect nuclear receptors mRNA overexpression in FFPE breast cancer tissue samples for selection of tamoxifen therapyCorrelation of HER2 overexpression with gene amplification and its relation to chromosome 17 aneuploidy: a 5-year experience with invasive ductal and lobular carcinomasQuantitative RT-PCR assay of HER2 mRNA expression in formalin-fixed and paraffin-embedded breast cancer tissuesQuantitative immunohistochemical analysis reveals association between sodium iodide symporter and estrogen receptor expression in breast cancer.Expression of osteopontin coregulators in primary colorectal cancer and associated liver metastases.Added value of HER-2 amplification testing by multiplex ligation-dependent probe amplification in invasive breast cancerModular strategy for the construction of radiometalated antibodies for positron emission tomography based on inverse electron demand Diels-Alder click chemistry.Subtypes of oligodendroglioma defined by 1p,19q deletions, differ in the proportion of apoptotic cells but not in replication-licensed non-proliferating cells.Optimizing HER2 assessment in breast cancer: application of automated image analysis.Analysis of HER2 gene amplification using an automated fluorescence in situ hybridization signal enumeration system.Monocyte-Induced Prostate Cancer Cell Invasion is Mediated by Chemokine ligand 2 and Nuclear Factor-κB ActivityRevisiting determinants of prognosis in cutaneous melanoma.Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patientsValidation of a new classifier for the automated analysis of the human epidermal growth factor receptor 2 (HER2) gene amplification in breast cancer specimens.Prognostic significance of HER2 gene amplification according to stage of breast cancerHER Receptor Family: Novel Candidate for Targeted Therapy for Gallbladder and Extrahepatic Bile Duct Cancer.From bench to bedside: the growing use of translational research in cancer medicine.Clinical and health economic outcomes of alternative HER2 test strategies for guiding adjuvant trastuzumab therapy.Digital image analysis: a review of reproducibility, stability and basic requirements for optimal results.State-of-the-art FISHing: automated analysis of cytogenetic aberrations in interphase nuclei.Implementation of whole slide imaging in surgical pathology: A value added approachOverexpression and gene amplification of EGFR, HER2, and HER3 in biliary tract carcinomas, and the possibility for therapy with the HER2-targeting antibody pertuzumab.Correlation of breast cancer subtypes, based on estrogen receptor, progesterone receptor, and HER2, with functional imaging parameters from ⁶⁸Ga-RGD PET/CT and ¹⁸F-FDG PET/CT.Reproducibility of immunostaining quantification and description of a new digital image processing procedure for quantitative evaluation of immunohistochemistry in pathology.Digital image analysis of membrane connectivity is a robust measure of HER2 immunostains.Tissue microarray technology in the routine assessment of HER-2 status in invasive breast cancer: a prospective study of the use of immunohistochemistry and fluorescence in situ hybridization.The role of biomarkers in the future of drug development.Validation of immunoexpression of tenascin-C in oral precancerous and cancerous tissues using ImageJ analysis with novel immunohistochemistry profiler plugin: An immunohistochemical quantitative analysis.PIK3CA amplification and PTEN loss in diffused large B-cell lymphoma.Differential pathological response to preoperative chemotherapy across breast cancer intrinsic subtypes.Evaluation of the HER2 amplification status in oesophageal adenocarcinoma by conventional and automated FISH: a tissue microarray study.A meta-analysis on concordance between immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) to detect HER2 gene overexpression in breast cancer.
P2860
Q27333953-ED7F6C35-DB25-496A-B8E3-EEE43E59BBBBQ28568266-23824B19-925B-4A93-8DDE-4CD275119F1CQ33243793-DED9A06C-DFCE-4A76-A04E-C54C6024DA5FQ33454999-87159C82-EB15-4E02-983A-2F045790E10FQ33566937-1BEF1AA1-610A-474F-B27E-4D777D9289A7Q34044859-7E420F24-419A-4A80-A74C-BEC2E337FF6CQ34129444-CB6CBA8D-3167-459F-B3FA-DF99D1ED0212Q34146042-140D1F55-8479-4331-90BF-CEC76936E670Q34371359-3E57F01E-15BF-4507-ADBF-96628C288FE4Q34371749-E68E7BD7-EA08-4090-881F-C31B183868C7Q34501712-05B261B4-97B9-46D8-811C-87C5766507CCQ34559087-0F708AF4-864A-474E-8589-4362A5B36ED6Q34727239-DDF725EE-6465-4B69-9FD3-FE4A42ACF57EQ35064067-FF6C7B2E-DE4E-4EAA-8890-245E0D9EEE43Q35394166-6A10F633-534C-4647-9152-A842174FCAB7Q35608413-D23C4DE8-E6B9-42E2-B098-5F4E21A0FCB2Q35673706-A3DE0165-6B3A-4AF9-B4B6-3B5192E82C0DQ35789621-E4A72433-A9A2-40FA-A727-1982876C49D3Q35994680-C7F7D407-1C79-45C4-841D-287745797B4DQ36338825-10E6ADF9-9019-4115-9102-593775A72999Q36643014-5721DE52-688E-47B7-91ED-BD8CBFA6A326Q36646136-29305359-1819-4835-B91E-DE93A334E921Q36854475-681A9178-927D-4E12-870D-A8048B147B0FQ37073441-A5E182D8-6BEC-4AAD-B427-B213CD77461BQ37698244-EE707A6F-03B0-4A32-A107-03089F70DF82Q37889274-DCB48636-90AE-4E70-B813-4993BF472997Q37994831-DDE9715B-6094-4BD8-9115-0BEADCF63D6CQ38018578-A569FA8E-A5E4-4A9A-BC75-A845C1489ACAQ38363920-B128866E-8CDF-4FA0-8234-6B7AAD2B1D99Q38390565-073CD5DA-FACD-499C-9E91-0A75EBFBFE34Q38440214-DD3B91B4-BE98-4721-8B5B-3D4939668356Q39891932-9393CCFE-AD86-4215-BD7C-18281C488EF3Q39980300-5B6EAB0D-953B-4BD7-8D99-06D02F1A6B51Q40089438-2AF7CEBA-9E9F-40F4-BD60-ABCC3C2962E5Q40302734-4C8B3CEC-C46D-4003-B54A-C3035DB430EBQ41162496-7E624B8A-6A53-4F22-A3B9-666BAA08B9B9Q42371625-2FDC8556-BCDA-4311-8190-2E41F0BF4EDEQ42517316-295F713B-87E0-4E53-9460-C48277879622Q43684798-924C2F7E-BB01-4634-974D-D57D4EED6599Q45782977-A5CBF6E4-2455-4853-AADC-A800C06CA46F
P2860
HER2 amplification status in breast cancer: a comparison between immunohistochemical staining and fluorescence in situ hybridisation using manual and automated quantitative image analysis scoring techniques.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
HER2 amplification status in b ...... e analysis scoring techniques.
@ast
HER2 amplification status in b ...... e analysis scoring techniques.
@en
type
label
HER2 amplification status in b ...... e analysis scoring techniques.
@ast
HER2 amplification status in b ...... e analysis scoring techniques.
@en
prefLabel
HER2 amplification status in b ...... e analysis scoring techniques.
@ast
HER2 amplification status in b ...... e analysis scoring techniques.
@en
P2093
P2860
P356
P1476
HER2 amplification status in b ...... e analysis scoring techniques.
@en
P2093
E L Maltby
T J Stephenson
P2860
P304
P356
10.1136/JCP.2004.023424
P407
P577
2005-07-01T00:00:00Z